期刊文献+

PIK3CA基因突变在结直肠癌中的研究进展 被引量:1

Research progress of PIK3CA gene mutation in colorectal cancer
下载PDF
导出
摘要 结直肠癌是较常见的恶性肿瘤,发病率在我国呈逐年上升趋势。肿瘤的发生是多因素、多阶段、多基因改变的结果,包括原癌基因的激活与抑癌基因的失活。PIK3CA基因是近年发现的除KRAS突变之外的结直肠癌常见的突变基因,PI3K下游信号通路的异常活化在结直肠癌的发生过程中发挥着重要的作用。本文就PIK3CA基因的生物学作用,参与肿瘤不同阶段的发展,以及PIK3CA作为肿瘤标志物和分子靶点的潜在临床价值简要作一综述。 Colorectal cancer is a common malignant tumor,incidence is increasing year by year in China.Tumor is many factors,many stages and more the result of genetic changes,including the activation of oncogene and tumor suppressor gene inactivation.In recent years,PIK3CA mutation is very common in addition to KRAS mutations in colorectal cancer,PI3K signaling pathways downstream of the abnormal activation play an important role in colorectal cancer happen process.In this paper,we reviewed the biological role of PIK3CA gene,the function of PIK3CA gene in different stages of tumor development,and the potential clinical value of PIK3CA gene as tumor biomarker and molecular target.
出处 《现代肿瘤医学》 CAS 2013年第11期2635-2638,共4页 Journal of Modern Oncology
关键词 PIK3CA基因 结直肠癌 基因突变 标志物 肿瘤治疗 PIK3CA gene colorectal cancer gene mutation biomarker tumor therapy
  • 相关文献

参考文献47

  • 1Jemal A,Bray F,Center MM,et al. Global cancer statistics[J]. CA Cancer J Clin,2011,61 (2) :69 -90.
  • 2Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012 [ J ]. CA Cancer J Clin,2012,62(2) :10 -29.
  • 3Roper J, Richardson MP, Wanq WV, et al. The dual PI3K/mTOR inhibitor NVP - BEZ235 induces tumor regression in a genetically engineered mouse model of PIK3CA wild - type colorectal cancer [J]. PloS One,2011,6(9) :e25132.
  • 4杨阳,邹多武,朱伟,李兆申,蔡全才.西妥昔单抗联合化疗治疗晚期结直肠癌疗效的meta分析[J].中国肿瘤生物治疗杂志,2012,19(3):303-308. 被引量:12
  • 5Amado RG, Wolf M, Peeters M, et al. Wild type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer[ J]. J Clin Oncol,2008,26(10) :1626 -1634.
  • 6Bokemeyer C, Kohne C, Rougier P, et al. Cetuximab with chemo- therapy (CT) as first - line treatment for metastatic coloreetal cancer (mCRC) :Analysis of the CRYSTAL and OPUS studies ac- cording to KRAS and BRAF mutation status [J]. J Clin Oncol, 2010,28(15s) :3506.
  • 7Siena S, Sartore - Bianchi A, Di Nicolantonio F, et al. Biomarkers predicting clinical outcome of epidermal growth factor receptor - targeted therapy in metastatic colorectal cancer [ J ]. J Natl Cancer Inst,2009,101 : 1308 - 1324.
  • 8Garrido - Laguna I, Hong DS, Janku F, et al. KRASness and PIK3 CAness in patients with advanced eoloreetal cancer:Outcome after treatment with early - phase trials with targeted pathway in- hibitors [ J ]. PLoS ONE ,2012,7 (5) : e38033.
  • 9Ligresti G, Militello L, Steelman LS, et al. PIK3 CA mutations in hu- man solid tumors:role in sensitivity to various therapeutic approa- ches[J]. Cell Cycle,2009,8(9) :1352 -1358.
  • 10Guo JP, Coppola D, Cheng JQ. IKBKE protein activates Akt inde- pendent of phosphatidylinositol 3 - kinase/PDKl/mTORC2 and the pleckstrin homology domain to sustain malignant transforma- tion[J]. J Biol Chem,2011,286(43) :37389 -37398.

二级参考文献82

  • 1Alex T, Merav YL. Akt signaling and cancer= surviving but not moving orL Cancer Res, 2006,66(8) :3963-3966.
  • 2Samuels Y, Diaz LA Jr , Schmidt-kittler O, et al. Mutant PIK3CA promotes cell growth and invasion of human cancer cells[J]. Cancer Cell ,2005,7(6) :561-573.
  • 3Guo XN, RajPut A, Rose R, et al. Mutant PIK3CA-bearing colon cancer ceils display increased metastasis in an orthotopic model [J]. Cancer Res,2007,67(12) :5851-5858.
  • 4Samuels Y, Wang Z, Bardelli A, et al. High frequency of mutations of the PIK3CA gene in human cancers [J]. Science, 2004, 304(5670) :554-554.
  • 5Bachman KE, Argani P, Samuels Y, et al. The PIK3CA gene is mutated with high frequency in human breast cancers [J]. Cancer Biol Ther,2004,3(8) :772-775.
  • 6Seal LH, Holm K, Maurer M, et al. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with glEN loss in human breast carcinoma [J]. Cancer Res 2005,65(7) :2554 - 2559.
  • 7Campbell IG, Russell SE, Choong DY, et al. Mutation of the PIK3CA gene in ovarian and breast cancer[J]. Cancer Res, 2004, 64(21) :7678-7681.
  • 8Buttitta F, Felicioni L, Barassi F, et al. PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma [J]. J Pathol ,2006,208(3):350- 355.
  • 9I.i SY, Rong M, Grieu F, Iacopetta B. PIK3CA mutations in breast cancer are associated with poor outcome [J]. Breast Cancer Res Treat, 2006;96(1) :91-95.
  • 10Maruyama N, Miyoshi Y, Taguchi T, et al. Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women [J]. Clin Cancer Res,2007,13(2 Pt 1):408-414.

共引文献20

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部